Therapies and Vaccination for Cardiovascular Diseases

Atherosclerosis is that the major cause of acute cardiovascular events such as myocardial infarction and stroke. Current therapies focusing on risk factor reduction, primarily by treatment with sterol lowering statins, have tested to cut back the danger of ischaemic cardiovascular events by up to 400th in randomised clinical trials. Though this has considerably down cardiovascular disease mortality, the majority of patients treated with medicine medical aid are still without effective CVD protection. Through experimental, clinical and medical specialty research, therefore, targeting the inflammatory disease method within the coronary-artery disease plaque represents an exciting new frontier for medical aid development.

 

  • antigen-specific Treg cells
  • Immune tolerance to atherosclerotic antigens
  • Anti-CD3 antibodies
  • Anti-CD3 antibodies
  • IL-2 and IL-2/anti-IL-2 immune complex
  • Vitamin D3
  • Tolerogenic vaccines

Related Conference of Therapies and Vaccination for Cardiovascular Diseases

October 25-26, 2018

21st World Obesity Conference

Budapest, Hungary
November 29-30, 2018

International Conference on Obesity and Diet Imbalance

Bali, Indonesia
January 31, February 01, 2019

18th International Conference on Obesity, Diet and Nutrition

Paris | France
March 15-16, 2019

International Conference on Bariatric and Metabolic Surgery

Brisbane, Australia
March 18 - 19, 2019, New York, USA

Obesity, Diet Management & Nutrition Conference

June 21-22, 2019

21st Global Obesity Meeting

Brisbane, Australia

Therapies and Vaccination for Cardiovascular Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in